ZMIZ1 and colonic neoplasm: Using in vitro cellular and loss-of-function assays, this study demonstrated that ZMIZ1 plays a critical pro-cancer role in colon cancer and that targeting ZMIZ1 is beneficial in hindering colon cancer progression.